Retatrutide is not FDA approved. Learn why buying it online or in stores is not legal or safe, and how licensed pharmacy compounding is different.
The Wegovy Pill passed 3 million prescriptions. What $149 self-pay covers, what the 25 mg dose costs, and how the pill compares to the shot.
A real patient shares his Gimme Care experience, from a 3-minute intake to $199/month compounded tirzepatide. See pros, tradeoffs, and what to know.
The FDA moved 12 peptides off its restricted list and reviews 7 in July 2026. See what it could mean for compounding, your GLP-1, and peptide safety.
B12, B6, niacinamide, glycine, benzyl alcohol: see what each GLP-1 additive does, the allergy risks, and how to search providers by additive.
Staying on a GLP-1 this summer? See how to avoid dehydration, store your pen below 86°F, travel safely, and what's true about sun sensitivity.
Insurers and employers are cutting GLP-1 coverage mid-year. See why, how to tell if your plan changed, cash-pay options from $299, and how to appeal.
CagriSema is under FDA review with a decision expected in 2026. See what the trials showed and how it compares to Wegovy and Zepbound.
What the research shows about GLP-1 medications for PCOS, including weight, testosterone, periods, and why it is still an off-label use.
A real patient shares her TrimRX experience, from flat $279 tirzepatide pricing to slow support, a warm late delivery, and a mismatched vial label.
The Medicare GLP-1 Bridge starts July 1, 2026. See who qualifies, which drugs cost $50, and how the prior authorization works step by step.
How GLP-1 medications affect weight, muscle, and bone in menopause, plus steps midlife women can take to protect lean mass and bone health.
%2520doing%2520lap%2520swimming%2520in%2520a%2520long%2520outdoor%2520pool.png&w=3840&q=100)
